search
Back to results

Pizza-Salami Study in Children and Adolescents With Type 1 Diabetes

Primary Purpose

Type 1 Diabetes Mellitus

Status
Completed
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
CFP counting
CARB counting
Sponsored by
Kinderkrankenhaus auf der Bult
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Type 1 Diabetes Mellitus focused on measuring CSII, prandial insulin requirements, bolus calculation, dual-wave bolus

Eligibility Criteria

6 Years - 21 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients with type 1 diabetes
  • Age 6 - 21 years
  • Diabetes duration > 1 year
  • Treatment with pump therapy (CSII) > 3 months
  • Written informed consent by patients and parents
  • Patients must be willing to wear a glucose sensor for two days and to perform capillary blood glucose measurement twice a day
  • Patients must be willing to performed all study procedures

Exclusion Criteria:

  • Language barriers
  • Eating disorders
  • Pregnancy
  • Drug abuse
  • Patient refutes participation or study procedures

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Active Comparator

    Arm Label

    CARB Counting

    CFP counting

    Arm Description

    For CARB counting, insulin dose will be calculated according to the carbohydrate content of the test meal (1 carb unit = 10 g carbohydrate). The insulin-to-carbohydrate ratio will be applied according to the current individual therapy of the patient.

    For CFP counting, insulin dose will be calculated according the carbohydrate content (1 carb unit = 10 g carbohydrate) as well as fat/protein content (1 FPU = 100 kcal from fat and protein) of the meal. The insulin-to-carbohydrate ratio will be applied according to the current individual therapy of the patient. The insulin-to-FPU ratio is the same as the insulin to carb ratio.

    Outcomes

    Primary Outcome Measures

    CGM-Glucose Area Under the Curve
    CGM = Continuous Glucose Monitoring

    Secondary Outcome Measures

    Time of glucose nadir
    hyperglycemia (6h-AUC >180 mg/dl)
    AUC = Area Under the Curve
    frequency and amount of interventional hypoglycemic therapy
    i.e. g of glucose required to treat hypoglycemia
    frequency of adverse events (incl. SAE)
    Hospital stay was from 2h before until 6h after teast meal. SAE = Severe Adverse Event

    Full Information

    First Posted
    July 20, 2011
    Last Updated
    December 17, 2015
    Sponsor
    Kinderkrankenhaus auf der Bult
    Collaborators
    Medtronic
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT01400659
    Brief Title
    Pizza-Salami Study in Children and Adolescents With Type 1 Diabetes
    Official Title
    The PIZZA-Salami Trial: Monocentric Randomised Cross-over Study of Carb Counting vs. Carb Plus Fat/Protein Counting Based Insulin Bolus Used for Sensor-augmented Continuous Subcutaneous Insulin Infusion (CSII) in Pediatric Patients
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    December 2015
    Overall Recruitment Status
    Completed
    Study Start Date
    March 2009 (undefined)
    Primary Completion Date
    July 2009 (Actual)
    Study Completion Date
    November 2009 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Kinderkrankenhaus auf der Bult
    Collaborators
    Medtronic

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The Pizza-Salami-Study aims to investigate the efficacy of carbohydrate plus fat/protein (CFP) counting compared with carbohydrate (CARB) counting using normal and dual-wave bolus in sensor-augmented pump therapy in children and adolescents with type 1 diabetes. For fat/protein counting the model used by Pankowska et al. will be applied.
    Detailed Description
    This is a prospective, international multi-centre, open randomized clinical trial to assess whether the use of Paradigm REAL-Time System from the onset of Type 1 Diabetes (T1D) leads to a better glycaemic control after 12 months of T1D compared with the use of Paradigm 515/715 insulin pump combined with conventional Self-Monitoring Blood Glucose finger-sticks in paediatric patients. Total randomized treatment duration of the study for a patient will be 12 months with an optional phase of follow-up of 3 months.Patients eligible according to inclusion and exclusion criteria will be randomized to one of the two treatment groups. A total of 160 patients will be recruited. Each subject will participate in the study for 15 months, which includes 12 months of treatment and 3 months of follow-up. Each patient is asked to use either the Paradigm REAL-Time System that provides a combination of insulin pump and the Real-Time continuous glucose monitoring or Paradigm 515/715 insulin pump combined to conventional SMBG finger-sticks. Main time-points of assessments are at baseline (within one month after T1D onset) and 12 months thereafter. In total, there will be 6 study visits at the local site. During study, patients will regularly attend the outpatient clinic according to local Standard care, i.e. every 8±2 weeks.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Type 1 Diabetes Mellitus
    Keywords
    CSII, prandial insulin requirements, bolus calculation, dual-wave bolus

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 4
    Interventional Study Model
    Crossover Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    42 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    CARB Counting
    Arm Type
    Active Comparator
    Arm Description
    For CARB counting, insulin dose will be calculated according to the carbohydrate content of the test meal (1 carb unit = 10 g carbohydrate). The insulin-to-carbohydrate ratio will be applied according to the current individual therapy of the patient.
    Arm Title
    CFP counting
    Arm Type
    Active Comparator
    Arm Description
    For CFP counting, insulin dose will be calculated according the carbohydrate content (1 carb unit = 10 g carbohydrate) as well as fat/protein content (1 FPU = 100 kcal from fat and protein) of the meal. The insulin-to-carbohydrate ratio will be applied according to the current individual therapy of the patient. The insulin-to-FPU ratio is the same as the insulin to carb ratio.
    Intervention Type
    Procedure
    Intervention Name(s)
    CFP counting
    Other Intervention Name(s)
    CFP algorithm according to Pankowska et al.
    Intervention Description
    Patients receive a standardized test meal at lunch time. The required insulin dose is calculated by CFP counting. Insulin is given as bolus and basal rate using an insulin pump. Continuous glucose monitoring is performed by sensor-augmented pump system for 6 hours after the meal. The intervention is taking part under in-patient clinical conditions.
    Intervention Type
    Procedure
    Intervention Name(s)
    CARB counting
    Other Intervention Name(s)
    CARB algorithm
    Intervention Description
    Patients receive a standardized test meal at lunch time. The required insulin dose is calculated by CARB counting. Insulin is given as bolus and basal rate using an insulin pump. Continuous glucose monitoring is performed by sensor-augmented pump system for 6 hours after the meal. The intervention is taking part under in-patient clinical conditions.
    Primary Outcome Measure Information:
    Title
    CGM-Glucose Area Under the Curve
    Description
    CGM = Continuous Glucose Monitoring
    Time Frame
    6 hours after the test meal
    Secondary Outcome Measure Information:
    Title
    Time of glucose nadir
    Time Frame
    6 hours after the test meal
    Title
    hyperglycemia (6h-AUC >180 mg/dl)
    Description
    AUC = Area Under the Curve
    Time Frame
    6 h after the test meal
    Title
    frequency and amount of interventional hypoglycemic therapy
    Description
    i.e. g of glucose required to treat hypoglycemia
    Time Frame
    6 h after the test meal
    Title
    frequency of adverse events (incl. SAE)
    Description
    Hospital stay was from 2h before until 6h after teast meal. SAE = Severe Adverse Event
    Time Frame
    during hospitalization period of the study

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    6 Years
    Maximum Age & Unit of Time
    21 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Patients with type 1 diabetes Age 6 - 21 years Diabetes duration > 1 year Treatment with pump therapy (CSII) > 3 months Written informed consent by patients and parents Patients must be willing to wear a glucose sensor for two days and to perform capillary blood glucose measurement twice a day Patients must be willing to performed all study procedures Exclusion Criteria: Language barriers Eating disorders Pregnancy Drug abuse Patient refutes participation or study procedures
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Olga Kordonouri, MD
    Organizational Affiliation
    Kinderkrankenhaus auf der Bult
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Citations:
    PubMed Identifier
    20513322
    Citation
    Pankowska E, Blazik M. Bolus calculator with nutrition database software, a new concept of prandial insulin programming for pump users. J Diabetes Sci Technol. 2010 May 1;4(3):571-6. doi: 10.1177/193229681000400310.
    Results Reference
    background
    PubMed Identifier
    22765260
    Citation
    Kordonouri O, Hartmann R, Remus K, Blasig S, Sadeghian E, Danne T. Benefit of supplementary fat plus protein counting as compared with conventional carbohydrate counting for insulin bolus calculation in children with pump therapy. Pediatr Diabetes. 2012 Nov;13(7):540-4. doi: 10.1111/j.1399-5448.2012.00880.x. Epub 2012 Jul 6.
    Results Reference
    derived

    Learn more about this trial

    Pizza-Salami Study in Children and Adolescents With Type 1 Diabetes

    We'll reach out to this number within 24 hrs